Akèy › Dematomiyozit › Texas › Houston
Etid klinik pou Dematomiyozit nan Houston, TX
5 etid pou Dematomiyozit ap chèche patisipan nan sit nan ak bò kote Houston (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
Ap rekriteFaz 1
- UT MD Anderson Cancer Center, Houston
RESET-Myositis: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Idiopathic Inflammatory Myopathy or Juvenile Idiopathic Inflammatory Myopathy
Ap rekriteFaz 2/3
- Houston Methodist Hospital - Accepting Adult Patients, Houston
- University of Texas MD Anderson Cancer Center - Accepting Adult Patients, Houston
A Study to Understand How the Study Medicine (PF-06823859) Works in People With Active Idiopathic Inflammatory Myopathies [Dermatomyositis (DM) and Polymyositis (PM)]
Ap rekriteFaz 3
- Nerve & Muscle Center of Texas, Houston
A Study to Understand How the Study Medicine Dazukibart Works in People With Idiopathic Inflammatory Myopathies
Ap rekriteFaz 3
- Nerve & Muscle Center of Texas, Houston
Phase 1b Trial of RAY121 in Immunological Diseases (RAINBOW Trial)
Ap rekriteFaz 1
- Nerve and Muscle Center of Texas, Houston
Etid Dematomiyozit nan lòt vil
- Durham, NC8 etid
- Washington, DC7 etid
- New York City, NY5 etid
- Pittsburgh, PA5 etid
- Boston, MA5 etid
- Philadelphia, PA4 etid
- Baltimore, MD4 etid
- Miami, FL4 etid
- Cleveland, OH3 etid
- Kansas City, KS3 etid
- Jacksonville, FL3 etid
- Aurora, CO3 etid
Lòt etid nan Houston
- Kansè Poumon ki pa ti selil145 etid
- Kansè nan tete126 etid
- Kansè (tout kalite)121 etid
- Kansè Metastatik104 etid
- Kansè kolorektal102 etid
- Kansè ovè89 etid
- Leksemi mieloïd egi85 etid
- Kansè poumon78 etid
- Kansè pwostat76 etid
- Kansè Endomèt68 etid
- Kansè pankreyas61 etid
- Melanom59 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.